Why Partner?
Rakan Kongsi
为何选择成为合作伙伴？
Can You See Yourself Empowering Cell Therapy Advancements?
Cell therapy in Asia is changing the face of the industry as it now accounts for over a third of all cell therapy trials and boasts 5 commercialized treatments on the market. As this space begins to dominate, are you positioning yourself as a leader for this market?
The CAR-TCR Cell Therapy Summit Asia is a premier event for stakeholders in the APAC cell therapy industry, bringing together leading experts from big pharma, biotech, and service providers.
This summit is a unique platform for vendors to showcase tailored services and solutions, addressing the specific needs of cell therapy development. Big pharma and biotech have specifically requested to hear from vendors that can provide tailored services and solutions in:
Cell-specific raw materials and cell banks for
best quality drug
products
Identifying the most appropriate preclinical models to
support translational
research
Streamlining analytical methodologies to assess in vivo cell activity to create minimally invasive cell therapies
Developing enhanced antibody services to minimize off-target effects and enhance therapeutic efficacy
Fine-tuning existing sequencing techniques to maximize the identification of novel TCR, CAR-T and NK targets
Manufacturing platforms and engineering strategies to minimize cell damage and maximize metabolic profiles
Sample Attendee Breakdown
